EVODIAMINE

SynDRA canonical compound SYN0010077 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	TRPV1
Mechanism of action	ATPase inhibitor \| TRPV agonist

All known targets

d-Evodiamine
(+)-Evodiamine
Evodiamine, (+)-
CHEBI:4948
C01825BVNL
CHEMBL463165
(S)-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one
(S)-14-methyl-7,8,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(13H)-one
MFCD06407824
(1S)-21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one
UNII-C01825BVNL
Evodiamine,(S)
(13bS)-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one
EVODIAMINE [MI]
EVODIAMINE [WHO-DD]
MLS006011787
SCHEMBL682158
DTXSID10966123
ZINC898159
BCP02282
HY-N0114
BBL033833
BDBM50560847
STK801981
AKOS005622478
CS-6161
SMR001934404
VS-12304
C09187
518E172
Q-100579
Q27894193
Evodiamine, European Pharmacopoeia (EP) Reference Standard
(1S)-21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,15,17,19-HEPTAEN-14-ONE
Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-
Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-
INDOLO(2',3':3,4)PYRIDO(2,1-B)QUINAZOLIN-5(7H)-ONE, 8,13,13B,14-TETRAHYDRO-14-METHYL-, (13BS)-
R-(-)-evodiamine